Imunon director granted 5,011 shares at $2.20

Braun Donald P reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Braun Donald P reported acquisition or exercise transactions in this Form 4 filing.

Imunon, Inc. director Donald P. Braun received a grant of 5,011 shares of Common Stock on May 22, 2026 at a price of $2.20 per share. This was stock granted in lieu of cash for a portion of his board fees. Following this award, he directly holds 9,319 shares of Imunon common stock.

Insider Trade Summary

Grant/Award: 5,011 shares

Grant/Award 1 txn

Insider Braun Donald P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,011	$2.20	$11K

Holdings After Transaction: Common Stock — 9,319 shares (Direct)

Footnotes (1)

1. F1. Stock granted in lieu of cash for portion of board fees

Key Figures

Shares granted: 5,011 shares Grant price: $2.20 per share Shares owned after grant: 9,319 shares

3 metrics

Shares granted 5,011 shares Common Stock award on May 22, 2026

Grant price $2.20 per share Reported value for stock granted in lieu of cash

Shares owned after grant 9,319 shares Director Donald P. Braun direct holdings post-transaction

Key Terms

Common Stock, grant/award acquisition, non-derivative, stock granted in lieu of cash

4 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

non-derivative financial

"transaction_type: "non-derivative""

stock granted in lieu of cash financial

"Stock granted in lieu of cash for portion of board fees"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Imunon (IMNN) report for Donald P. Braun?

Imunon reported that director Donald P. Braun received 5,011 shares of Common Stock as a grant on May 22, 2026. The shares were issued as stock in lieu of cash for a portion of his board fees, reflecting routine director compensation.

At what price were the Imunon (IMNN) shares granted to Donald P. Braun?

The 5,011 Imunon shares granted to Donald P. Braun were valued at $2.20 per share. This price is used for reporting the transaction value on the Form 4 and reflects the grant, not an open-market purchase or sale.

How many Imunon (IMNN) shares does Donald P. Braun hold after this grant?

After receiving the 5,011-share grant, Donald P. Braun directly holds 9,319 shares of Imunon Common Stock. This total represents his direct ownership reported in the filing and reflects his updated position following the compensation-related award.

Was the Imunon (IMNN) Form 4 transaction a market buy or sell?

The transaction was not a market buy or sell. It is classified as a grant or award acquisition, where shares were issued to Donald P. Braun as compensation in lieu of cash for part of his board fees, rather than purchased or sold on the market.

What does “stock granted in lieu of cash for board fees” mean for Imunon (IMNN)?

It means Imunon paid a portion of Donald P. Braun’s board compensation using shares instead of cash. He received 5,011 shares valued at $2.20 each, converting part of his director fees into equity, a common form of non-cash board compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/27/2026 - 04:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Braun Donald P

(Last) (First) (Middle)

C/O IMUNON, INC.

997 LENOX DRIVE, SUITE 100

(Street)

LAWRENCEVILLE NEW JERSEY 08648

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Imunon, Inc. [ IMNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/22/2026		A		5,011(1)	A	$2.2	9,319	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Stock granted in lieu of cash for portion of board fees

Remarks:

On August 21, 2025, the Issuer paid a 15% stock dividend, 0.15 shares of common stock per share of the Issuer's issued and outstanding shares of common stock, to stockholders of record as of August 7, 2025. As a result of the stock dividend, the shares of Issuer Common Stock have been adjusted accordingly versus any amounts previously reported by the Reporting Person.

	/s/ Susan Eylward, Attorney-in-Fact for Donald P. Braun	05/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)